Public Notification: Triple SupremeZen Plus 3500 contains hidden drug ingredient
[04/16/2021] Update: This product has been recalled by Hyobin LLC doing business as Yolo Studio. See the company’s press release for more information on the recall. This product was sold by Yolo Studio via Amazon fulfillment. See FDA’s press release for additional information.
[12-17-2020] The Food and Drug Administration is advising consumers not to purchase or use SupremeZen Plus 3500, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.
FDA laboratory analysis confirmed that SupremeZen Plus 3500 purchased from Amazon.com contains tadalafil, the active ingredient in Cialis, an FDA-approved prescription drug for erectile dysfunction. FDA approval of Cialis is restricted to use under the supervision of a licensed health care professional. This undeclared ingredient may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels. People with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.
Health care professionals and patients are encouraged to report adverse events or side effects related to the use of this product to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:
- Complete and submit the report online at MedWatch Online Voluntary Reporting Form, or;
- Download and complete the form, then submit it via fax at 1-800-FDA-0178.
Note: This notification is to inform the public of a growing trend of dietary supplements or conventional foods with hidden drugs and chemicals. These products are typically promoted for sexual enhancement, weight loss, and body building and are often represented as being “all natural.” FDA is unable to test and identify all products marketed as dietary supplements that have potentially harmful hidden ingredients. Consumers should exercise caution before purchasing any product in the above categories.
Please refer to the links below for more information: